Evidence map›Paper›PMID 30056122›Full record

ArticleNeuropharmacology2018

Increasing Brain-Derived Neurotrophic Factor (BDNF) in medial prefrontal cortex selectively reduces excessive drinking in ethanol dependent mice.

Harold L Haun, William C Griffin, Marcelo F Lopez, Matthew G Solomon, Patrick J Mulholland, John J Woodward, Jacqueline F McGinty, Dorit Ron, Howard C Becker

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Orbitofrontal BDNF puts the brakes on alcohol intake and relapse.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Increased Synaptic Strength and mGluAlcoholism, clinical and experimental research · 2021
    Article
  18. Article
  19. Growth Factors and Alcohol Use Disorder.Cold Spring Harbor perspectives in medicine · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Harold L HaunCharleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, USA; Department of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
William C GriffinCharleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, USA.
Marcelo F LopezCharleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, USA.
Matthew G SolomonCharleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, USA; Department of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
Patrick J MulhollandCharleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, USA; Department of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
John J WoodwardCharleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, USA; Department of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
Jacqueline F McGintyDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA.
Dorit RonDepartment of Neurology, University of California at San Francisco School of Medicine, San Francisco, CA, 94158, USA.
Howard C BeckerCharleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, 29425, USA; Department of Neuroscience, Medical University of South Carolina, Charleston, SC, 29425, USA; RHJ Department of Veterans Affairs Medical Center, Charleston, SC, 20401, USA. Electronic address: beckerh@musc.edu.
Medical University of South Carolina · USUniversity of California, San Francisco · US

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWARD C. BECKER · 1996 to 2026
$46.8M
Ethanol Dependence &Stress Effects on Ethanol DrinkingU01AA014095 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWARD C. BECKER · 2003 to 2026
$9.0M
TRAINING IN ALCOHOL TREATMENT RESEARCHT32AA007474 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI John J. Woodward · 1987 to 2026
$8.5M
BDNF and Alcohol AddictionR37AA016848 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RON, DORIT · 2013 to 2022
$3.7M
Mouse Chronic Intermittent Ethanol (CIE) CoreU24AA020929 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LOPEZ, MARCELO F. · 2016 to 2021
$1.1M
Role of BDNF in Stress Effects on Ethanol Dependence-Induced Escalated DrinkingI01BX000813 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI BECKER, HOWARD C. · 2011 to 2024
–
BLRD VA I01 BX000813NIAAA NIH HHS P50 AA010761NIAAA NIH HHS R37 AA016848NIAAA NIH HHS T32 AA007474NIAAA NIH HHS U01 AA014095NIAAA NIH HHS U24 AA020929
6 · The paper itself

Abstract

The neurotrophin Brain-Derived Neurotrophic Factor (BDNF) has been implicated in a number of neuropsychiatric disorders, including alcohol use disorder. Studies have shown that BDNF activity in cortical regions, such as the medial prefrontal cortex (mPFC) mediates various ethanol-related behaviors. We previously reported a significant down-regulation in Bdnf mRNA in mPFC following chronic ethanol exposure compared to control mice. The present study was conducted to extend these findings by examining whether chronic ethanol treatment reduces BDNF protein expression in mPFC and whether reversing this deficit via direct injection of BDNF or viral-mediated overexpression of BDNF in mPFC alters voluntary ethanol consumption in dependent and nondependent mice. Repeated cycles of chronic intermittent ethanol (CIE) exposure was employed to model ethanol dependence, which produces robust escalation of ethanol intake. Results indicated that CIE treatment significantly increased ethanol intake and this was accompanied by a significant decrease in BDNF protein in mPFC that lasted at least 72 h after CIE exposure. In a separate study, once dependence-related increased drinking was established, bilateral infusion of BDNF (0, 0.25, 0.50 μg) into mPFC significantly decreased ethanol intake in a dose-related manner in dependent mice but did not affect moderate drinking in nondependent mice. In a third study, viral-mediated overexpression of BDNF in mPFC prevented escalation of drinking in dependent mice but did not alter intake in nondependent mice. Collectively, these results provide evidence that adaptations in cortical (mPFC) BDNF activity resulting from chronic ethanol exposure play a role in mediating excessive ethanol drinking associated with dependence.

Indexed as

Alcohol DrinkingAlcoholismAnimalsBrain-Derived Neurotrophic FactorDose-Response Relationship, DrugEthanolGenetic VectorsMaleMiceMicroinjectionsPrefrontal CortexBrain-Derived Neurotrophic FactorEthanolBDNFEthanol dependenceEthanol drinkingMedial prefrontal cortexMice

Identifiers

PMID30056122
PMCPMC6113096
OpenAlexW2884204411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.